Acceleron Pharma, Inc. operates as a biopharmaceutical company. The company engages in developing, manufacturing, and commercializing novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases. Its products include ACE-011 Program, a novel bone forming agent that helps to treat cancer-related bone loss; ACE-031 Program that helps to treat diseases involving the loss of muscle mass, strength, and function in diseases, including muscular dystrophy, amyotrophic lateral sclerosis, and cancer-related muscle loss; and ACE-041, a protein therapeutic that binds a member of the growth and differentiation factor family necessary for angiogenesis. It develops therapies based on growth and differentiation factors that regulate the cellular proliferation, differentiation, and survival of a range of tissue types. The company offers treatments for cancer-related bone loss, cancer-related muscle loss, neuromuscular diseases, and metabolic disorders. Acceleron Pharma, Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Acceleron Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Acceleron Pharma Inc market cap is $10.93B.
What is the 52-week high for Acceleron Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Acceleron Pharma Inc 52 week high is $189.99 as of April 26, 2024.
What is the 52-week low for Acceleron Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Acceleron Pharma Inc 52 week low is $111.29 as of April 26, 2024.
What is Acceleron Pharma Inc stock price today?
Acceleron Pharma Inc stock price today is $178.75.
What was Acceleron Pharma Inc stock price yesterday?
Acceleron Pharma Inc stock price yesterday was $179.68.
What is the PE ratio of Acceleron Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Acceleron Pharma Inc’s P/E ratio is -42.53.
What is the Price-to-Book ratio of Acceleron Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Acceleron Pharma Inc P/B ratio is 15.2156.
What is the 50-day moving average of Acceleron Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Acceleron Pharma Inc 50-day moving average is $169.49.